FDA Approves Label Supplement for iDose TR episode artwork

EPISODE · Jan 28, 2026 · 5 MIN

FDA Approves Label Supplement for iDose TR

from Eyewire News: The Podcast · host Eyewire News

The FDA approves a key label supplement for Glaukos’ iDoseTR; Nidek announces the European launch of a new open-field refraction system; and there have been several leadership changes announced during the first month of 2026. Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

FDA Approves Label Supplement for iDose TR

0:00 5:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 5 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on January 28, 2026.

What is this episode about?

The FDA approves a key label supplement for Glaukos’ iDoseTR; Nidek announces the European launch of a new open-field refraction system; and there have been several leadership changes announced during the first month of 2026. Learn more about your...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!